Results 261 to 270 of about 104,517 (284)
Some of the next articles are maybe not open access.
Neurologic Clinics, 2019
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising overlapping phenotypes of cranial arteritis and extracranial GCA. Vascular complications are generally due to delay in diagnosis and initiation of effective treatment.
Karina Lazarewicz, Pippa Watson
openaire +6 more sources
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising overlapping phenotypes of cranial arteritis and extracranial GCA. Vascular complications are generally due to delay in diagnosis and initiation of effective treatment.
Karina Lazarewicz, Pippa Watson
openaire +6 more sources
Vision loss in giant cell arteritis
Practical Neurology, 2021Almost two-thirds of patients with giant cell arteritis (GCA) develop ocular symptoms and up to 30% suffer permanent visual loss. We review the three most common mechanisms for visual loss in GCA, describing the relevant ophthalmic arterial anatomy and ...
Laura Donaldson, Edward A. Margolin
semanticscholar +1 more source
Ustekinumab for the Treatment of Giant Cell Arteritis
Arthritis care & research, 2020To evaluate the efficacy and safety of ustekinumab (UST) in giant cell arteritis (GCA).
M. Matza +3 more
semanticscholar +1 more source
Prevalence of Giant Cell Arteritis Relapse in Patients Treated With Glucocorticoids: A Meta‐Analysis
Arthritis care & research, 2020The relapse rate of patients with giant cell arteritis (GCA) treated with glucocorticoids (GCs) alone varied widely in observational series and randomized controlled trials (RCTs).
Sabine Mainbourg +10 more
semanticscholar +1 more source
Rheumatic Disease Clinics of North America, 1995
Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA.
Bo-Erik Malmvall +4 more
openaire +3 more sources
Whereas giant cell arteritis (GCA) was considered a rare disease 50 years ago, the generalized arteritis is now recognized as an important and significant cause of morbidity in elderly people; its cause and pathogenesis is poorly understood. Glucocorticosteroids are the drug of choice in all clinical types of GCA.
Bo-Erik Malmvall +4 more
openaire +3 more sources
The Journal of Emergency Medicine, 1986
Giant-cell or temporal arteritis is a generalized vasculitis that predominantly affects large- and medium-sized arteries in people over 50 years of age. The illness is commonly characterized by the initial symptoms of headache, temporal artery tenderness or pulselessness, musculoskeletal pain, fever, and fatigue.
Reginald K. Sherard, Samuel T. Coleridge
openaire +3 more sources
Giant-cell or temporal arteritis is a generalized vasculitis that predominantly affects large- and medium-sized arteries in people over 50 years of age. The illness is commonly characterized by the initial symptoms of headache, temporal artery tenderness or pulselessness, musculoskeletal pain, fever, and fatigue.
Reginald K. Sherard, Samuel T. Coleridge
openaire +3 more sources
Arthritis care & research, 2020
To investigate the association between specimen length and number of sections evaluated and the diagnostic yield of temporal artery biopsy (TAB) for giant cell arteritis (GCA).
F. Muratore +10 more
semanticscholar +1 more source
To investigate the association between specimen length and number of sections evaluated and the diagnostic yield of temporal artery biopsy (TAB) for giant cell arteritis (GCA).
F. Muratore +10 more
semanticscholar +1 more source
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Annals of the Rheumatic Diseases, 2020We read with much interest the article entitled “Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis”,1 reporting a reduction in the requests for fast-track assessment of giant ...
A. Lecler +3 more
semanticscholar +1 more source
International Journal of Rheumatic Diseases, 2020
Positron emission tomography/computed tomography (PET/CT) can detect cranial and large vessel inflammation in giant cell arteritis (GCA). We aimed to determine the change and significance of vascular activity at diagnosis and 6 months.
A. Sammel +10 more
semanticscholar +1 more source
Positron emission tomography/computed tomography (PET/CT) can detect cranial and large vessel inflammation in giant cell arteritis (GCA). We aimed to determine the change and significance of vascular activity at diagnosis and 6 months.
A. Sammel +10 more
semanticscholar +1 more source
Arthritis & Rheumatology, 2019
Positron emission tomography/computed tomography (PET/CT) has not been well studied as a first‐line test for giant cell arteritis (GCA), due, in part, to historical limitations in visualizing the cranial arteries.
A. Sammel +12 more
semanticscholar +1 more source
Positron emission tomography/computed tomography (PET/CT) has not been well studied as a first‐line test for giant cell arteritis (GCA), due, in part, to historical limitations in visualizing the cranial arteries.
A. Sammel +12 more
semanticscholar +1 more source